Free Trial
Andrew S. Fein

Andrew S. Fein Analyst Performance

Managing Director at HC Wainwright

Andrew S. Fein is a stock analyst at HC Wainwright focused in the healthcare sector, covering 72 publicly traded companies. Over the past year, Andrew S. Fein has issued 79 stock ratings, including strong buy, buy, and hold recommendations. While full access to Andrew S. Fein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andrew S. Fein's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
544 Last 12 Years
Buy Recommendations
92.31% 492 Buy Ratings
Companies Covered
72 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.1%6 ratings
Buy91.2%486 ratings
Hold7.7%41 ratings
Sell0.0%0 ratings

Out of 533 total stock ratings issued by Andrew S. Fein at HC Wainwright, the majority (91.2%) have been Buy recommendations, followed by 7.7% Hold and 1.1% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
90.3% of companies on NASDAQ
65 companies
NYSEAMERICAN
2.8% of companies on NYSEAMERICAN
2 companies
OTCMKTS
2.8% of companies on OTCMKTS
2 companies
NYSE
2.8% of companies on NYSE
2 companies
TSE
1.4% of companies on TSE
1 company

Andrew S. Fein, an analyst at HC Wainwright, currently covers 72 companies listed on NASDAQ, NYSEAMERICAN, OTCMKTS, NYSE and TSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
69 companies
95.8%
Industrials
2 companies
2.8%
Materials
1 company
1.4%

Andrew S. Fein of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Industrials and Materials companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
57 companies
79.2%
PHARMACEUTICALS
11 companies
15.3%
TRADING COMPANIES & DISTRIBUTORS
1 company
1.4%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
1.4%
CHEMICALS
1 company
1.4%
AEROSPACE & DEFENSE
1 company
1.4%

About Andrew S. Fein

Mr. Fein is a Managing Director of Equity Research at H.C. Wainwright. Mr. Fein conducted more than twelve years of biotechnology equity research. Prior to joining H.C. Wainwright, Mr. Fein worked as the Head of the Healthcare Research effort at Chardan Capital Markets. Mr. Fein began his career at J.P. Morgan H&Q and first gained recognition as a Senior Analyst at Leerink Swann. After that, Mr. Fein worked as a Managing Director/Senior Biotechnology Analyst at Jefferies, Piper Jaffray and Collins Stewart. Mr. Fein has received numerous honorable mentions from the Institutional Investor All-America Research poll. Mr. Fein’s educational background includes a Bachelor of Arts degree from Yale University.
Follow on LinkedIn

Andrew S. Fein's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Alector, Inc. stock logo
ALEC
Alector
11/6/2026Initiated Coverage$2.29Strong-Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
11/6/2026Initiated Coverage$175.92Strong-Buy
Prothena Corporation plc stock logo
PRTA
Prothena
11/6/2026Initiated Coverage$8.73Strong-Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
11/5/2026Initiated Coverage$29.50Strong-Buy
Insmed, Inc. stock logo
INSM
Insmed
11/4/2026Initiated Coverage$104.44$220.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
10/28/2026Initiated Coverage$3.64Strong-Buy
Insmed, Inc. stock logo
INSM
Insmed
10/27/2026Reiterated Rating$93.33Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
10/20/2026Reiterated Rating$122.96Buy
Liquidia Corporation stock logo
LQDA
Liquidia
10/15/2026Boost Price Target$33.94$65.00Buy
Alector, Inc. stock logo
ALEC
Alector
10/14/2026Boost Price Target$1.87$8.00Buy
Insmed, Inc. stock logo
INSM
Insmed
10/12/2026Reiterated Rating$100.60$220.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
10/12/2026Lower Price Target$138.77$246.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
10/2/2026Reiterated Rating$3.88Buy
Liquidia Corporation stock logo
LQDA
Liquidia
10/2/2026Lower Price Target$27.99$58.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
8/18/2026Boost Price Target$33.16$55.00Buy
Insmed, Inc. stock logo
INSM
Insmed
8/10/2026Reiterated Rating$131.10Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
8/3/2026Reiterated Rating$5.51Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
7/31/2026Reiterated Rating$493.11Buy
Biogen Inc. stock logo
BIIB
Biogen
7/30/2026Boost Price Target$205.31$251.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
7/24/2026Set Price Target$88.44$36.00
Liquidia Corporation stock logo
LQDA
Liquidia
7/23/2026Boost Price Target$89.25$130.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
7/22/2026Reiterated Rating$143.94$270.00Buy
Insmed, Inc. stock logo
INSM
Insmed
7/20/2026Reiterated Rating$108.32$220.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
7/10/2026Reiterated Rating$1.73Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
6/30/2026Reiterated Rating$9.86$32.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
6/11/2026Reiterated Rating$5.66Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
6/8/2026Reiterated Rating$13.32$34.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
6/5/2026Boost Price Target$62.32$75.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
6/5/2026Set Price Target$63.95$28.00
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
6/2/2026Downgrade$6.42$3.00Neutral
Catalyst Pharmaceuticals, Inc. stock logo
CPRX
Catalyst Pharmaceuticals
5/28/2026Downgrade$31.32$31.50Neutral
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
5/20/2026Reiterated Rating$4.34Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
5/19/2026Lower Price Target$6.40$13.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
5/18/2026Reiterated Rating$1.11$20.00Buy
Biogen Inc. stock logo
BIIB
Biogen
5/14/2026Reiterated Rating$195.04Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/12/2026Boost Price Target$53.30$67.00Buy
Insmed, Inc. stock logo
INSM
Insmed
5/8/2026Reiterated Rating$101.30Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
5/6/2026Reiterated Rating$502.47$620.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
5/1/2026Downgrade$26.66$27.00Neutral
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
4/29/2026Boost Price Target$6.96$24.00Buy
Every Starlink dish pays this stock (Ad)

There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel

Claim your free stock pick before December 8th
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
4/29/2026Boost Price Target$5.06$27.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
4/14/2026Lower Price Target$7.26$18.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/7/2026Boost Price Target$132.48$215.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/2/2026Boost Price Target$183.78$237.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
3/31/2026Boost Price Target$583.78$660.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
3/27/2026Lower Price Target$1.27$20.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
3/26/2026Boost Price Target$22.47$42.00Buy
Insmed, Inc. stock logo
INSM
Insmed
3/26/2026Boost Price Target$149.18$245.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3/25/2026Reiterated Rating$13.66$34.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3/24/2026Boost Price Target$115.73$270.00Buy
Savara Inc. stock logo
SVRA
Savara
3/16/2026Reiterated Rating$5.22Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
3/10/2026Boost Price Target$460.87$641.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
3/6/2026Boost Price Target$34.52$55.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3/4/2026Boost Price Target$14.67$34.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/2/2026Reiterated Rating$13.93$30.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
2/26/2026Boost Price Target$503.28$600.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
2/24/2026Boost Price Target$117.90$255.00Buy
Insmed, Inc. stock logo
INSM
Insmed
2/23/2026Reiterated Rating$164.91$230.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/17/2026Set Price Target$491.47$591.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Boost Price Target$465.02$518.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Lower Price Target$137.44$192.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
2/10/2026Boost Price Target$14.22$28.00Buy
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$201.18$228.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
1/9/2026Boost Price Target$15.82$37.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
1/6/2026Boost Price Target$8.21$40.00Buy
Savara Inc. stock logo
SVRA
Savara
12/23/2025Boost Price Target$6.47$10.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
12/19/2025Boost Price Target$15.84$30.00Buy
Insmed, Inc. stock logo
INSM
Insmed
12/18/2025Lower Price Target$165.88$230.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/18/2025Set Price Target$20.80$40.00
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
12/17/2025Boost Price Target$148.74$198.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/15/2025Set Price Target$91.07$200.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/15/2025Reiterated Rating$18.37$35.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
12/15/2025Boost Price Target$7.58$32.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/11/2025Boost Price Target$97.90$190.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/9/2025Boost Price Target$94.30$134.00Buy
Kamada Ltd. stock logo
KMDA
Kamada
12/9/2025Boost Price Target$6.73$13.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
12/8/2025Boost Price Target$8.90$25.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
11/24/2025Boost Price Target$11.29$18.00Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
11/21/2025Boost Price Target$556.75$620.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
11/11/2025Lower Price Target$8.69$9.00Neutral
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
11/11/2025Boost Price Target$524.24$568.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
11/7/2025Boost Price Target$12.36$20.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
11/7/2025Boost Price Target$10.19$30.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
11/6/2025Boost Price Target$75.75$190.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
11/5/2025Boost Price Target$59.91$84.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
11/4/2025Boost Price Target$27.25$50.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/30/2025Boost Price Target$450.79$525.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
10/29/2025Reiterated Rating$14.55$20.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
10/24/2025Reiterated Rating$12.00$12.00Neutral
Alector, Inc. stock logo
ALEC
Alector
10/22/2025Lower Price Target$1.52$5.00Buy
Your father's savings lost half their value after 1971. (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
10/20/2025Reiterated Rating$8.99$12.00Buy
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
10/10/2025Reiterated Rating$54.08$54.00Neutral
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
10/10/2025Downgrade$53.88$54.00Neutral
Prothena Corporation plc stock logo
PRTA
Prothena
10/7/2025Boost Price Target$9.86$20.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
10/6/2025Reiterated Rating$22.43$35.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/18/2025Boost Price Target$48.12$70.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
9/5/2025Boost Price Target$380.47$500.00Buy
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
9/4/2025Initiated Coverage$7.44$7.44Neutral
MetaVia Inc. stock logo
MTVA
MetaVia
9/4/2025Initiated Coverage$7.36$132.00Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
9/4/2025Initiated Coverage$435.27$500.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
9/4/2025Initiated Coverage$17.19$60.00Buy
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
9/4/2025Initiated Coverage$45.62$72.00Buy
Savara Inc. stock logo
SVRA
Savara
9/3/2025Boost Price Target$3.39$8.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
9/3/2025Reiterated Rating$7.55$22.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
8/15/2025Boost Price Target$46.10$75.00Buy
Savara Inc. stock logo
SVRA
Savara
8/15/2025Upgrade$3.01$5.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
8/7/2025Lower Price Target$6.11$18.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
8/6/2025Lower Price Target$6.88$25.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/5/2025Lower Price Target$472.27$478.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
8/5/2025Reiterated Rating$6.94$14.00Buy
Biogen Inc. stock logo
BIIB
Biogen
8/1/2025Boost Price Target$128.00$194.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
7/31/2025Set Price Target$281.95$400.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
7/29/2025Upgrade$7.65$12.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
7/8/2025Boost Price Target$15.06$27.00Buy
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
6/30/2025Upgrade$4.90$23.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
6/26/2025Reiterated Rating$46.47$60.00Buy
Biogen Inc. stock logo
BIIB
Biogen
6/26/2025Reiterated Rating$127.31$187.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/26/2025Reiterated Rating$22.50$32.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
6/23/2025Reiterated Rating$440.87$550.00Buy
Insmed, Inc. stock logo
INSM
Insmed
6/11/2025Boost Price Target$90.93$120.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
6/2/2025Set Price Target$7.51$24.00
Savara Inc. stock logo
SVRA
Savara
5/29/2025Downgrade$2.14$2.00Neutral
PepGen, Inc. stock logo
PEPG
PepGen
5/29/2025Lower Price Target$1.58$8.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/28/2025Boost Price Target$15.60$35.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
5/27/2025Lower Price Target$6.58$14.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
5/19/2025Boost Price Target$22.26$32.00Buy
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
5/14/2025Upgrade$4.21Strong-Buy
Annexon, Inc. stock logo
ANNX
Annexon
5/14/2025Lower Price Target$1.75$14.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
5/14/2025Lower Price Target$8.90$35.00Buy
Insmed, Inc. stock logo
INSM
Insmed
5/12/2025Reiterated Rating$65.08$90.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/12/2025Reiterated Rating$15.32$29.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
5/9/2025Lower Price Target$11.32$38.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
5/9/2025Boost Price Target$4.65$16.00Buy
PepGen, Inc. stock logo
PEPG
PepGen
5/9/2025Lower Price Target$1.58$14.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
5/9/2025Lower Price Target$7.43$30.00Buy
Alector, Inc. stock logo
ALEC
Alector
5/9/2025Boost Price Target$1.11$10.00Buy
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
5/8/2025Lower Price Target$13.68$25.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
5/7/2025Lower Price Target$13.55$32.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/6/2025Reiterated Rating$11.03$30.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
5/5/2025Reiterated Rating$294.60$425.00Buy
My $247 scanner for $7 (Ad)

Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel

Get the Instant Scanner for $7 in the Black Friday sale today.
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
5/5/2025Boost Price Target$8.95$16.00Buy
Biogen Inc. stock logo
BIIB
Biogen
5/2/2025Lower Price Target$121.39$187.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
5/2/2025Lower Price Target$7.08$24.00Buy
AC Immune stock logo
ACIU
AC Immune
5/1/2025Lower Price Target$1.73$12.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
4/30/2025Reiterated Rating$23.44$38.00Buy
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
4/29/2025Reiterated Rating$8.97$20.00Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/22/2025Lower Price Target$100.68$168.00Buy
Insmed, Inc. stock logo
INSM
Insmed
4/22/2025Reiterated Rating$69.51$90.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
4/7/2025Reiterated Rating$6.56$81.00Buy
AC Immune stock logo
ACIU
AC Immune
4/3/2025Reiterated Rating$1.88$16.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
4/1/2025Reiterated Rating$27.99$38.00Buy
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
4/1/2025Reiterated Rating$10.19$40.00Buy
Savara Inc. stock logo
SVRA
Savara
3/28/2025Reiterated Rating$2.78$6.00Buy
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
3/28/2025Lower Price Target$1.23$11.00Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
3/27/2025Reiterated Rating$1.76$10.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/26/2025Reiterated Rating$9.75$22.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
3/20/2025Reiterated Rating$14.92$29.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
3/19/2025Reiterated Rating$8.87$47.00Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
3/17/2025Reiterated Rating$1.77$10.00Buy
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
3/17/2025Reiterated Rating$8.10$20.00Neutral
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/17/2025Reiterated Rating$12.23$46.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
3/14/2025Reiterated Rating$12.25$20.00Buy
AC Immune stock logo
ACIU
AC Immune
3/14/2025Reiterated Rating$2.30$16.00Buy
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
3/14/2025Boost Price Target$1.74$12.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
3/11/2025Reiterated Rating$8.49$81.00Buy
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
3/7/2025Reiterated Rating$4.50$13.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
3/6/2025Initiated Coverage$3.06$8.00Buy
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
3/6/2025Reiterated Rating$3.63$23.00Buy
Kamada Ltd. stock logo
KMDA
Kamada
3/6/2025Reiterated Rating$7.10$11.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
3/6/2025Reiterated Rating$1.92$15.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3/5/2025Reiterated Rating$3.01$12.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/5/2025Reiterated Rating$11.23$22.00Buy
Merus N.V. stock logo
MRUS
Merus
3/3/2025Reiterated Rating$47.09$85.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
2/28/2025Lower Price Target$13.17$46.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
2/28/2025Boost Price Target$29.98$60.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
2/28/2025Boost Price Target$18.60$87.00Buy
Catalyst Pharmaceuticals, Inc. stock logo
CPRX
Catalyst Pharmaceuticals
2/28/2025Reiterated Rating$21.83$35.00Buy
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
2/27/2025Lower Price Target$10.94$40.00Buy
Alector, Inc. stock logo
ALEC
Alector
2/27/2025Reiterated Rating$1.72$7.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/27/2025Reiterated Rating$18.96$27.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
2/27/2025Reiterated Rating$318.89$425.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
2/26/2025Reiterated Rating$3.70$4.00Neutral
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
2/25/2025Reiterated Rating$8.29$30.00Buy
PepGen, Inc. stock logo
PEPG
PepGen
2/24/2025Reiterated Rating$2.81$16.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/21/2025Reiterated Rating$116.11$185.00Buy
Insmed, Inc. stock logo
INSM
Insmed
2/21/2025Reiterated Rating$83.61$90.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
2/21/2025Reiterated Rating$15.25$48.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
2/18/2025Reiterated Rating$8.51$75.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
2/18/2025Boost Price Target$9.74$47.00Buy
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$133.43$241.00Buy
Every Starlink dish pays this stock (Ad)

There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel

Claim your free stock pick before December 8th
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Reiterated Rating$469.97$550.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
2/11/2025Reiterated Rating$15.72$38.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
2/10/2025Reiterated Rating$10.15$75.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Lower Price Target$150.51$185.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/31/2025Boost Price Target$438.40$550.00Buy
PepGen, Inc. stock logo
PEPG
PepGen
1/30/2025Lower Price Target$1.84$16.00Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
1/29/2025Lower Price Target$1.98$10.00Buy
Kamada Ltd. stock logo
KMDA
Kamada
1/10/2025Reiterated Rating$7.32$11.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
1/10/2025Reiterated Rating$14.25$38.00Buy
Catalyst Pharmaceuticals, Inc. stock logo
CPRX
Catalyst Pharmaceuticals
1/10/2025Boost Price Target$22.80$35.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
1/10/2025Reiterated Rating$30.24$75.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
1/10/2025Reiterated Rating$15.68$55.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
1/3/2025Reiterated Rating$12.00$38.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/26/2024Initiated Coverage$11.80$38.00Buy